Hepatocellular Carcinoma with Segmental Portal Vein Invasion Exhibiting a Complete Response after Transarterial Radioembolization
- Author:
Jun Sik YOON
1
;
Su Jong YU
;
Yun Bin LEE
;
Eun Ju CHO
;
Jeong Hoon LEE
;
Yoon Jun KIM
;
Jung Hwan YOON
Author Information
- Publication Type:Case Report
- Keywords: Hepatocellular carcinoma; Venous thrombosis; Radiotherapy; Therapeutic embolization; Yttrium-90
- MeSH: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Portal Vein; Protons; Radiotherapy; Venous Thrombosis
- From:Journal of Liver Cancer 2019;19(2):159-164
- CountryRepublic of Korea
- Language:English
- Abstract: The treatment options available for patients with hepatocellular carcinoma (HCC) with portal vein invasion (PVI) include sorafenib, transarterial radioembolization (TARE), radiation therapy (RT), transarterial chemoembolization with RT, and proton beam irradiation. Herein, we present a case of HCC with segmental PVI that was managed via TARE. The patient had a 4 cm HCC that invaded the segment VIII portal vein branch without extrahepatic spread. Liver function was Child-Pugh grade A, and performance status was good. TARE was performed without any adverse events, and a radiological complete response (CR) was achieved. Thereafter, the patient was followed-up every 3–6 months without any further treatment, and the CR was maintained for >3 years. Therefore, TARE may be a useful alternative therapeutic option for patients with HCC exhibiting segmental PVI.
